Literature DB >> 2587138

Neuropsychologic impairment in children with sickle cell anemia.

A V Swift1, M J Cohen, G W Hynd, J M Wisenbaker, K M McKie, G Makari, V C McKie.   

Abstract

In this study, the neuropsychologic functioning of 21 children with sickle cell anemia and 21 sibling controls, age range 7 through 16 years, with no history of neurologic disease, was examined. Outcome measures included tests of intelligence, constructional praxis, memory, and academic learning. On the Wechsler Intelligence Scale for Children--Revised, the sickle cell group had a mean Full Scale IQ of 77.7 (SD 12.4) compared with 94.3 (SD 11.0) for the control group. The profile of test scores was similar for the two groups, with the sickle cell group scoring significantly lower than the control group on almost all cognitive measures. Both groups showed academic achievement to be commensurate with their measured intellectual ability. These results suggest that subtle but significant and widespread neuropsychologic deficits are associated with sickle cell anemia even in the absence of neurologic complications. When and by what process this neuropsychologic impairment is caused needs to be determined.

Entities:  

Mesh:

Year:  1989        PMID: 2587138

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

1.  Cognitive functioning in children from Nigeria with sickle cell anemia.

Authors:  Olubusola B Oluwole; Robert B Noll; Daniel G Winger; Olu Akinyanju; Enrico M Novelli
Journal:  Pediatr Blood Cancer       Date:  2016-07-09       Impact factor: 3.167

Review 2.  Neuroimaging findings in sickle cell disease.

Authors:  S C Thust; C Burke; A Siddiqui
Journal:  Br J Radiol       Date:  2014-05-21       Impact factor: 3.039

Review 3.  Neuropsychological aspects of pediatric sickle cell disease.

Authors:  M C Kral; R T Brown; G W Hynd
Journal:  Neuropsychol Rev       Date:  2001-12       Impact factor: 7.444

4.  Brain morphometric analysis predicts decline of intelligence quotient in children with sickle cell disease: A preliminary study.

Authors:  Rong Chen; Jaroslaw Krejza; Michal Arkuszewski; Robert A Zimmerman; Edward H Herskovits; Elias R Melhem
Journal:  Adv Med Sci       Date:  2017-03-06       Impact factor: 3.287

5.  A comparative study of academic achievement of children with sickle cell anemia and their healthy siblings.

Authors:  Olusoga B Ogunfowora; Durotoye M Olanrewaju; Gregory I Akenzua
Journal:  J Natl Med Assoc       Date:  2005-03       Impact factor: 1.798

6.  Neurocognitive screening with the Brigance preschool screen-II in 3-year-old children with sickle cell disease.

Authors:  Banu Aygun; Jennifer Parker; Molly B Freeman; Alexis L Stephens; Matthew P Smeltzer; Song Wu; Jane S Hankins; Winfred C Wang
Journal:  Pediatr Blood Cancer       Date:  2010-11-11       Impact factor: 3.167

7.  Cognitive impairment in children with hemoglobin SS sickle cell disease: relationship to MR imaging findings and hematocrit.

Authors:  R Grant Steen; Mark A Miles; Kathleen J Helton; Susan Strawn; Winfred Wang; Xiaoping Xiong; Raymond K Mulhern
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

8.  A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia.

Authors:  Courtney D Thornburg; Natalia Dixon; Shelly Burgett; Nicole A Mortier; William H Schultz; Sherri A Zimmerman; Melanie Bonner; Kristina K Hardy; Agustin Calatroni; Russell E Ware
Journal:  Pediatr Blood Cancer       Date:  2009-05       Impact factor: 3.167

9.  Factors associated with lowered intelligence in homozygous sickle cell disease.

Authors:  S Knight; A Singhal; P Thomas; G Serjeant
Journal:  Arch Dis Child       Date:  1995-10       Impact factor: 3.791

10.  A psychometric evaluation of the PedsQL Family Impact Module in parents of children with sickle cell disease.

Authors:  Julie A Panepinto; Raymond G Hoffmann; Nicholas M Pajewski
Journal:  Health Qual Life Outcomes       Date:  2009-04-16       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.